Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission.

Author information

Affiliations

  • 1. Ian Edwin Haines, MBBS, Monash University at Cabrini Health, Malvern, Victoria, Australia; and George L. Gabor Miklos, PhD, Atomic Oncology, Sydney, New South Wales, Australia.
      Authors
    • Haines IE 1
    • Gabor Miklos GL 1
    (2 authors)

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 07 Nov 2019, 38(2):171-172
https://doi.org/10.1200/jco.19.01912 PMID: 31697588 

A comment on this article appears in "Reply to Farolfi et al and Haines et al." J Clin Oncol. 2020 Jan 10;38(2):173-174. This is a comment on "Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer." J Clin Oncol. 2019 Sep 10;37(26):2317-2328.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1200/jco.19.01912

Citations & impact 

Impact metrics

1
Citation
Jump to Citations

Alternative metrics

Altmetric item for https://www.altmetric.com/details/70018860
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/70018860

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.